51186 Patient-reported well-being using tildrakizumab in a real-world setting: 28-week interim data of the phase IV POSITIVE study
No Thumbnail Available
All Authors
Mrowietz,Ulrich
Psoriasis-Center
Kiel,Campus
Reguiai,Ziad
Daud閚,Esteban
Maul,Julia-Tatjana
Laws,Philip
Mburu,Sicily
Koscielny,Volker
Massana,Eric
LTHT Author
Laws, Philip
LTHT Department
Dermatology
Non Medic
Publication Date
2024
Item Type
Article
Language
Subject
Subject Headings
Abstract
Journal
Journal of the American Academy of Dermatology